跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
RUBIFEN RETARD 60 MG CAPSULAS DURAS DE LIBERACION MODIFICADA EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
RUBIFEN RETARD 60 MG CAPSULAS DURAS DE LIBERACION MODIFICADA EFG
Approved
STANDARD
RUBIFEN RETARD 60 MG CAPSULAS DURAS DE LIBERACION MODIFICADA EFG
Laboratorios Rubio S.A.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Oct 10, 2022
Approval ID
5c0ff6ff5c4595dd
Company
Laboratorios Rubio S.A.
Type
Standard
Approval Details
Approval Id
5c0ff6ff5c4595dd
Drug Cima Aemps Name
RUBIFEN RETARD 60 MG CAPSULAS DURAS DE LIBERACION MODIFICADA EFG
Register Number
88178
Holder Company Name
Laboratorios Rubio S.A.
Marketing Company Name
Laboratorios Rubio S.A.
Authorization Date
2022-10-10
Dosage Form
CÁPSULA DURA DE LIBERACIÓN MODIFICADA
Dose
60 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica. Psicótropos
Commercialized
No
Company Name
Laboratorios Rubio S.A.
Active Ingredients
METILFENIDATO HIDROCLORURO
60 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Oct 10, 2022
Approval ID
5c0ff6ff5c4595dd
Type
Standard
Back to CIMA-AEMPS Approvals